Craves Fred B
- SEC CIK
- 0001014095
No open-market purchases or sales filed in the past year.
Current role at each company
- MDGL Madrigal Pharmaceuticals, Inc.Directoras of Mar 14, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Craves Fred B as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 14, 2025 (view filing) | Mar 12-13 | 2 days | Craves Fred BDirector | SSale | −15.5K | $328.54 | −$5.08M | −4.2%350.1K after | 13 lots |
| Dec 5, 2024 (view filing) | Dec 3 | 2 days | Craves Fred BDirector | SSale | −3.60K | $315.31 | −$1.14M | −24.7%11.0K after | 2 lots |
| Nov 27, 2024 (view filing) | Nov 25 | 2 days | Craves Fred BDirector | SSale | −3.40K | $350.30 | −$1.19M | −18.9%14.6K after | 2 lots |
| May 16, 2024 (view filing) | May 14 | 2 days | Craves Fred BDirector | SSale | −22.5K | $212.87 | −$4.79M | −5.2%413.4K after | 10 lots10b5-1 |